Fundraising Fox
/Investor DB
Sign in

Brandon Capital — 2018 Investments

1 investments dated 2018 · listed companies and verified rows first · show all

Okogenokogen.comFeb 2018

Okogen is a clinical-stage ophthalmic pharmaceutical company developing a treatment for acute infectious conjunctivitis, covering both bacterial and viral forms.

BiotechHealthtechMedical DevicesPlano, US

Joshua Moriarty(Executive Officer, Director)inBrian Strem(Director, Promoter)Bradford Conlan(Director, Promoter)Eric J. Daniels(Executive Officer, Director, Promoter)Chris Smith(Director)Leighton Reid(Director)

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.